微电生理股价报25.18元 上半年净利润同比增92.02%

Core Viewpoint - Microelectrophysiology reported a decline in stock price on August 26, closing at 25.18 yuan, down 2.55% from the previous trading day, with a trading volume of 1.97 billion yuan [1] Company Summary - Microelectrophysiology operates in the medical device industry, focusing on the research, production, and sales of cardiac electrophysiology interventional diagnostic devices [1] - The company's main products include a three-dimensional cardiac electrophysiology mapping system and cardiac radiofrequency ablation catheters [1] - In the first half of 2025, the company achieved operating revenue of 224 million yuan, representing a year-on-year growth of 12.80%, and a net profit attributable to shareholders of 32.67 million yuan, up 92.02% year-on-year [1] - The growth in performance is attributed to an expansion in sales scale and effective cost reduction measures [1] - On the same day, the company announced the appointment of Lin Yishan as the securities affairs representative [1] Market Activity - On August 26, the net inflow of main funds into Microelectrophysiology was 1.59 million yuan, while the cumulative net outflow over the past five trading days reached 26.79 million yuan [1]